-
University of Georgia’s Covid-19 vaccine shows promise in test models
pharmaceutical-technology
April 22, 2020
A Covid-19 vaccine candidate developed by a research team at the University of Georgia (UGA) College of Veterinary Medicine has shown promise in test models.
-
RedHill Biopharma partners with NIAID for potential Covid-19 drug
pharmaceutical-technology
April 22, 2020
Israel-based RedHill Biopharma has partnered with the US National Institute of Allergy and Infectious Diseases (NIAID) to study its RHB-107 (upamostat, WX-671) drug candidate in non-clinical tests for the treatment of Covid-19.
-
CPL Launches Production of Hand-Sanitizer to Meet Critical Shortages
contractpharma
April 22, 2020
The first approved product is a hand sanitizer solution containing 80% alcohol in 60mL and 200mL bottles.
-
Bio-Rad Begins Shipping COVID-19 Antibody Test
contractpharma
April 22, 2020
Bio-Rad Laboratories has launched its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.
-
India's MoHFW seeks export ban of anti-TB drugs
expresspharma
April 22, 2020
Delay in production and receipt of supply may cause an acute shortage of these drugs, highlights Union Health Secretary.
-
‘COVID-19 gives an opportunity to rethink pharma logistics and supply chain’
expresspharma
April 22, 2020
Nearly 70 per cent of the country’s pharma exports are carried out through the GMR Hyderabad Air Cargo.
-
CSIR backs development of a drug for patients suffering from Gram-negative sepsis
expresspharma
April 22, 2020
CSIR announced that it will initiate a randomised, blinded, two arms, active comparator-controlled clinical trial to evaluate the efficacy of the drug for reducing mortality (deaths) in critically ill COVID-19 patients.
-
Novartis to test efficacy of old malaria drug against COVID-19
expresspharma
April 22, 2020
The company hopes to have data on its efficacy by June, a lead researcher for the trial told Reuters.
-
Cipla donates Rs 25 crores for COVID-19 relief fund
expresspharma
April 22, 2020
Cipla announced an INR 25 crore fund to support the Indian Government’s efforts to effectively combat the COVID-19 pandemic.
-
Pills for the good health of pharma companies
expresspharma
April 22, 2020
Rohitashwa Prasad, Partner, JSA outlines the business strategies that pharma companies need to adopt for risk mitigation to deal with the impact of COVID – 19.